Charles River’s Memphis cell therapy facility gains entry into European Union market
August 18, 2022 at 12:51 PM EDT
“Receiving the GMP certification allows [our] Memphis [facility] to manufacture commercial-grade cell therapy drug products for distribution in Europe.”